Endothelial function in young adult survivors of childhood acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 1, 2008, Pages 20-25

  Dengel, Donald R ^a,b   Ness, Kirsten K ^d   Glasser, Stephen P ^e   Williamson, Eric B ^a   Baker, K Scott ^c   Gurney, James G ^f  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Cardiovascular; Late effects; Neoplasms; Survivorship; Ultrasound; Vasodilation

Indexed keywords

GLYCERYL TRINITRATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SKULL IRRADIATION; STATISTICAL SIGNIFICANCE; ULTRASOUND;

ADULT; BRACHIAL ARTERY; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NITROGLYCERIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SEX FACTORS; SURVIVORS; VASODILATION; VASODILATOR AGENTS;

EID: 37849022388     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318159a593     Document Type: Article

References (34)

1. Gurney JG, Severson RK, Davis S, et al. Incidence of cancer in children in the United States: sex-, race-, and 1-year age-specific rates by histologic type. Cancer. 1995;75:2186-2195.
2. Ries LAG, Harkins D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006.
3. Oeffinger KC, Buchanan GR, Eshelman DA, et al. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2001;23:424-430.
4. Hochster H, Wasserheit C, Speyer J. Cardiotoxicity and cardioprotection during chemotherapy. Curr Opin Oncol. 1995;7:304-309.
5. Bristow MR, Thompson PD, Martin RP, et al. Early anthracycline cardiotoxicity. Am J Med. 1978;65:823-832.
6. Bristow MR, Billingham ME, Mason JW, et al. Clinical spectrum of anthracycline cardiotoxicity. Cancer Treat Rep. 1978;62:873-879.
7. Braverman AC, Antin JH, Plappert MT, et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol. 1991;9:1215-1223.
8. Gottdiener JS, Appelbaum FR, Ferrans VJ, et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med. 1981;141:758-763.
9. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubin therapy for acute lymphoblastic leukemia in childhood. N Eng J Med. 1991;324:808-815.
10. Ayash LJ, Wright JE, Tretyakov O, et al. Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response. J Clin Oncol. 1992;10:995-1000.
11. Morandi P, Ruffini PA, Benvenuto GM, et al. Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide. Bone Marrow Transplant. 2001;28:277-282.
12. Stamler J, Loh E, Roddy M, et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 1994;89:2035-2040.
13. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
14. Kubes P, Suzuki M, Granger D. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991;88:4651-4655.
15. Kuvin JT, Karas RH. Clinical utility of endothelial function testing: ready for prime time? Circulation. 2003;107:3243-3247.
16. Widlansky ME, Gocke N, Keaney JF, et al. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-1160.
17. Murata T, Yamawaki H, Yoshimoto R, et al. Chronic effect of doxorubicin on vascular endothelium assess by organ culture study. Life Sci. 2001;69:2685-2695.
18. Wu S, Ko Y, Teng M, et al. Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol. 2002;34:1595-1607.
19. Margolin JF, Steuber CP, Poplack DG. Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006:538-590.
20. Gurney JG, Ness KK, Sibley SD, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006;107:1303-1312.
21. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multiinstitutional collaborative project. Med Pediatr Oncol. 2002;38:229-239.
22. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk for atherosclerosis. Lancet. 1992;340:1111-1115.
23. Kelly AS, Wetzsteon RJ, Kaiser DR, et al. Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise. J Pediatr. 2004;145:731-736.
24. Kelly AS, Kaiser DR, Dengel DR, et al. Comparison of B-mode and echo-tracking methods of assessing flow-mediated dilation. Ultrasound Med Biol. 2004;30:1447-1449.
25. Hashimoto M, Akishita M, Eto M, et al. Modulation of endothelium- dependent flow-mediated dilation of the brachial artery by sex and menstrual cycle. Circulation. 1995;92:3431-3435.
26. Chow AY, Chin C, Dahl G, et al. Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study. J Clin Oncol. 2006;24:925-928.
27. Asai K, Kudej RK, Shen YT, et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Throm Vasc Biol. 2000;20:1493-1499.
28. Lewis TV, Dart AM, Chin-Dusting JP. Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol. J Am Coll Cardiol. 1999;33:805-812.
29. Lupattelli G, Lombardini R, Schillaci G, et al. Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles. Am Heart J. 2000;140:521-526.
30. Lundman P, Eriksson M, Stuehlinger M, et al. Mild to moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol. 2001;38:111-116.
31. Monti LD, Landoni C, Setola E, et al. Myocardial insulin resistance associated with chronic hypertriglyceridaemia and increased FFA levels in type 2 diabetic patients. Am J Physiol Heart Circ Physiol. 2004;287:H1225- H1231.
32. Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Circulation. 2002;106:1211-1218.
33. Bae JH, Bassenge E, Kim KB, et al. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis. 2001;115:517-523.
34. Anderson RA, Evans ML, Ellis GR, et al. The relationship between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis. 2001;154:475-448.